Key indicators: single-crystal X-ray study; T = 298 K; mean (C-C) = 0.005 Å; R factor = 0.034; wR factor = 0.089; data-to-parameter ratio = 14.1.
In the title compound, C 9 H 14 Br 2 NO 2 , the substituted ring exhibits a chair conformation. A crystallographic mirror plane, passing through the N atom, the O atoms and the C atom in the 4-position, bisects the molecule.
Related literature
For medical applications of similar compounds, see: Aubert et al. (2011) ; Brike (1990) ; Xu et al. (2009) . For puckering parameters see : Cremer & Pople(1975) .
Experimental
Crystal data 
The title compound was synthetized by reaction between 4-Oxo-2,2,6,6-tetramethylpiperidin-1-yl oxide (2 mmol) and bromine (2 mmol), dissolved in CH 2 CH 2 Cl 2 and mixed together for 2 h. Large block crystals were precipitated, filtered ,washed with ethanol and dried in air (yield 80%).
Refinement
All H atoms were positioned geometrically(C-H = 0.96-0.98 Å,) and were refined as riding, with U iso (H) = 1.2U eq (carrier) or 1.5U eq (methyl C). Figures   Fig. 1 . The molecular structure of (I) showing 30% probability displacement ellipsoids.
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